Cite

HARVARD Citation

    Tsao, C. et al. (2016). Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer. Oncologist. pp. 1414-e9. [Online]. 
  
Back to record